skip to content

Novavax

NOVAVAX NEWS

Novavax says its Covid-19 vaccine gets India authorisation for teens

March 23, 2022 8:50 am

Covovax is the fourth COVID-19 vaccine to be authorised for adolescents aged 12 years and older in India after Biological E's Corbevax, Zydus Cadila's ZyCoV-D and Bharat Biotech's Covaxin.

Serum Institute seeks EUA for its Covovax vaccine for 12-17 yrs age group

February 21, 2022 7:55 pm

The Drugs Controller General Of India has already approved Covovax for restricted use in emergency situations in adults on December 28.

AstraZeneca, Novavax say their shots protect from Omicron

December 23, 2021 6:02 pm

🔴 Coronavirus infections have soared across much of the world as the highly infectious Omicron variant has spread, triggering new curbs in many countries.

Novavax developing vaccine that targets new Covid-19 variant

November 27, 2021 8:35 am

The vaccine developer said it had started developing a spike protein specifically based on the known genetic sequence of the variant, B.1.1.529.

Novavax completes process for WHO emergency use approval of Covid-19 vaccine

November 05, 2021 9:13 am

The company submitted to the health agency all modules required for the evaluation of NVX-CoV2373, its protein-based Covid-19 vaccine, days after receiving its first emergency use authorization from Indonesia.

Covovax trials for children to start at Pune site on Monday

September 04, 2021 3:13 pm

This vaccine is the fourth one to undergo clinical trials in children in India.

Novavax says Taiwan has opted to get firm's Covid vaccine via COVAX

July 02, 2021 8:44 am

Taiwan's vaccine orders include 4.76 million doses from COVAX, though so far it has only received slightly more than 600,000 from the scheme, all AstraZeneca Plc shots.

Pushed by Supreme Court, Centre replies: Plan to vaccinate all adults by end of the year

June 27, 2021 8:59 am

In its affidavit, the Centre said that based on supply estimates, it estimates 51.6 crore cumulative vaccinations by the end of July.

SII-partner Novavax reports 90% efficacy, says focused first on developing countries

June 15, 2021 7:05 am

The Maryland-headquartered company said its vaccine had demonstrated 100 per cent protection in late-stage trials against moderate and severe disease caused by SARS-CoV-2 — a boost for the prospects of its Indian version, Covovax.

Serum Institute of India seeks DCGI's nod to manufacture Covid vaccine Sputnik V

June 03, 2021 5:04 pm

The Pune-based firm has collaborated with the Gamaleya Research Institute of Epidemiology and Microbiology, Moscow for developing Sputnik V at its Hadapsar facility.

Advertisement
Advertisement
Advertisement